125 related articles for article (PubMed ID: 2450356)
1. The antitumor effect of bleomycin combined with bestatin against Ehrlich ascites carcinoma in mice.
Kaya G; Akin C; Altuğ T; Devrim S
Proc Soc Exp Biol Med; 1988 Mar; 187(3):292-5. PubMed ID: 2450356
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral effect of bleomycin+dolomite combination treatment, in mice bearing Ehrlich ascites carcinoma.
Scheller S; Krol W; Skirmuntt K; Zydowicz G; Shani J
Z Naturforsch C J Biosci; 1993; 48(9-10):818-20. PubMed ID: 7504493
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of bestatin combined with bleomycin against hepatoma AH 66 subcutaneously transplanted in rats].
Abe F; Yamashita T; Takahashi K; Matsuda A; Ichikawa T; Umezawa H
Jpn J Antibiot; 1984 Apr; 37(4):589-92. PubMed ID: 6206250
[TBL] [Abstract][Full Text] [Related]
4. A review of clinical studies of bestatin.
Oka S
Recent Results Cancer Res; 1980; 75():126-32. PubMed ID: 7015425
[TBL] [Abstract][Full Text] [Related]
5. Antitumoral property of ethanolic extract of propolis in mice-bearing Ehrlich carcinoma, as compared to bleomycin.
Scheller S; Krol W; Swiacik J; Owczarek S; Gabrys J; Shani J
Z Naturforsch C J Biosci; 1989; 44(11-12):1063-5. PubMed ID: 2483616
[TBL] [Abstract][Full Text] [Related]
6. Effect of bestatin on syngeneic tumors in mice.
Abe F; Shibuya K; Uchida M; Takahashi K; Horinishi H; Matsuda A; Ishizuka M; Takeuchi T; Umezawa H
Gan; 1984 Jan; 75(1):89-94. PubMed ID: 6586596
[TBL] [Abstract][Full Text] [Related]
7. Pimaricin potentiation of bleomycin activity against murine tumors.
Komiyama K; Umezawa I; Kuwano M; Komiyama S
Gan; 1983 Aug; 74(4):602-6. PubMed ID: 6195041
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of antitumor activity of bleomycin by benzamide in vitro and in vivo.
Sakamoto H; Kawamitsu H; Miwa M; Terada M; Sugimura T
J Antibiot (Tokyo); 1983 Mar; 36(3):296-300. PubMed ID: 6187722
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of antitumor effect of bleomycin by lipid-surfactant mixed micelles. I. In vivo and tumor-neutralizing activity against mouse Ehrlich ascites tumor and rat ascites hepatoma AH66.
Yoshikawa H; Takada K; Muranishi S
J Pharmacobiodyn; 1985 Apr; 8(4):305-10. PubMed ID: 2411907
[TBL] [Abstract][Full Text] [Related]
10. Screening of small molecular microbial products modulating immune responses and bestatin.
Umezawa H
Recent Results Cancer Res; 1980; 75():115-25. PubMed ID: 7232823
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the combination of cisplatin and peplomycin on Ehrlich ascites carcinoma and on head and neck squamous cell carcinoma transplanted to nude mice].
Mashino S
Nihon Jibiinkoka Gakkai Kaiho; 1985 Apr; 88(4):502-11. PubMed ID: 2411898
[No Abstract] [Full Text] [Related]
12. [Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
Ota K; Kurita S; Yamada K; Masaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1017-25. PubMed ID: 3963846
[TBL] [Abstract][Full Text] [Related]
13. Effects of bleomycin on the cell cycle of Ehrlich ascites carcinoma.
Nagatsu M; Richart RM; Lambert A
Cancer Res; 1972 Sep; 32(9):1966-70. PubMed ID: 4118376
[No Abstract] [Full Text] [Related]
14. Toxicity and antitumor activity of niosomal bleomycin in tumor bearing mice.
Naresh RA; Udupa N; Devi PU
Indian J Exp Biol; 1996 Aug; 34(8):764-72. PubMed ID: 8979482
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of antitumor activity of bleomycin towards solid tumors in mice by Bacillus thuringiensis subsp. israelensis toxin.
Yokoyama Y; Ohmori I; Kohda K; Kawazoe Y
Anticancer Res; 1991; 11(4):1625-8. PubMed ID: 1720939
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of the cytotoxicity of peplomycin against Ehrlich ascites carcinoma by bleomycin hydrolase inhibitors.
Nishimura C; Nishimura T; Tanaka N; Suzuki H
J Antibiot (Tokyo); 1987 Dec; 40(12):1794-5. PubMed ID: 2448282
[No Abstract] [Full Text] [Related]
17. [Biological effect of bestatin against rat ascites hepatomas and enhancement of interferon production].
Satoh H
Jpn J Antibiot; 1984 Apr; 37(4):593-6. PubMed ID: 6206251
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of rhodium (II) complexes on mice bearing Ehrlich tumors.
Reibscheid EM; Zyngier S; Maria DA; Mistrone RJ; Sinisterra RD; Couto LG; Najjar R
Braz J Med Biol Res; 1994 Jan; 27(1):91-4. PubMed ID: 8173534
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy with bestatin for acute non-lymphocytic leukemia (ANLL) in adults].
Kurita S; Ota K; Yamada K; Massaoka T; Uzuka Y; Ogawa N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2742-50. PubMed ID: 6508324
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant bestatin (Ubenimex) treatment following full-dose local irradiation for bladder carcinoma.
Blomgren H; Esposti PL; Näslund I; Johansen L; Lemming O
Acta Oncol; 1990; 29(6):809-12. PubMed ID: 2223154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
